Tevaarwerk Amye J, Hocking William G, Zeal Jamie L, Gribble Mindy, Seaborne Lori, Buhr Kevin A, Wisinski Kari B, Burkard Mark E, Wiegmann Douglas A, Sesto Mary E
University of Wisconsin; Carbone Cancer Center, Madison; and Marshfield Clinic, Marshfield, WI.
J Oncol Pract. 2017 May;13(5):e486-e495. doi: 10.1200/JOP.2016.018648. Epub 2017 Feb 21.
Treatment summaries prepared as part of survivorship care planning should correctly and thoroughly report diagnosis and treatment information.
As part of a clinical trial, summaries were prepared for patients with stage 0 to III breast cancer at two cancer centers. Summaries were prepared per the standard of care at each center via two methods: using the electronic health record (EHR) to create and facilitate autopopulation of content or using manual data entry into an external software program to create the summary. Each participant's clinical data were abstracted and cross-checked against each summary. Errors were defined as inaccurate information, and omissions were defined as missing information on the basis of the Institute of Medicine recommended elements.
One hundred twenty-one summaries were reviewed: 80 EHR based versus 41 software based. Twenty-four EHR-based summaries (30%) versus six software-based summaries (15%) contained one or more omissions. Omissions included failure to provide dates and specify all axillary surgeries for EHR-based summaries and failure to specify receptors for software-based summaries. Eight EHR-based summaries (10%) versus 19 software-based summaries (46%) contained one or more errors. Errors in EHR-based summaries were mostly discrepancies in dates, and errors in software-based summaries included incorrect stage, surgeries, chemotherapy, and receptors.
A significant proportion of summaries contained at least one error or omission; some were potentially clinically significant. Mismatches between the clinical scenario and templates contributed to many of the errors and omissions. In an era of required care plan provision, quality measures should be considered and tracked to reduce rates, decrease inadvertent contributions from templates, and support audited data use.
作为幸存者护理计划一部分而编制的治疗总结应正确且全面地报告诊断和治疗信息。
作为一项临床试验的一部分,为两个癌症中心0至III期乳腺癌患者编制了总结。通过两种方法按照每个中心的护理标准编制总结:使用电子健康记录(EHR)创建并促进内容自动填充,或使用手动数据录入外部软件程序来创建总结。提取了每位参与者的临床数据,并与每份总结进行交叉核对。根据医学研究所推荐的要素,将错误定义为不准确的信息,遗漏定义为缺失的信息。
共审查了121份总结:80份基于EHR,41份基于软件。24份基于EHR的总结(30%)和6份基于软件的总结(15%)包含一个或多个遗漏。遗漏包括基于EHR的总结未提供日期和未明确所有腋窝手术,以及基于软件的总结未明确受体。8份基于EHR的总结(10%)和19份基于软件的总结(46%)包含一个或多个错误。基于EHR的总结中的错误大多是日期差异,基于软件的总结中的错误包括分期、手术、化疗和受体错误。
相当一部分总结至少包含一个错误或遗漏;有些可能具有潜在临床意义。临床情况与模板之间的不匹配导致了许多错误和遗漏。在需要提供护理计划的时代,应考虑并跟踪质量指标,以降低错误率,减少模板造成的无意影响,并支持经审核的数据使用。